These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 18478023)
1. Combined therapeutic strategy using erythropoietin and mesenchymal stem cells potentiates neurogenesis after transient focal cerebral ischemia in rats. Esneault E; Pacary E; Eddi D; Freret T; Tixier E; Toutain J; Touzani O; Schumann-Bard P; Petit E; Roussel S; Bernaudin M J Cereb Blood Flow Metab; 2008 Sep; 28(9):1552-63. PubMed ID: 18478023 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells after transient focal cerebral ischemia in rats. Pellegrini L; Bennis Y; Guillet B; Velly L; Garrigue P; Sabatier F; Dignat-George F; Bruder N; Pisano P Neurol Res; 2013 Nov; 35(9):937-47. PubMed ID: 23816235 [TBL] [Abstract][Full Text] [Related]
3. Combining erythropoietin infusion with intramyocardial delivery of bone marrow cells is more effective for cardiac repair. Zhang D; Zhang F; Zhang Y; Gao X; Li C; Yang N; Cao K Transpl Int; 2007 Feb; 20(2):174-83. PubMed ID: 17239026 [TBL] [Abstract][Full Text] [Related]
4. Lipoaspirate-derived adult mesenchymal stem cells improve functional outcome during intracerebral hemorrhage by proliferation of endogenous progenitor cells stem cells in intracerebral hemorrhages. Fatar M; Stroick M; Griebe M; Marwedel I; Kern S; Bieback K; Giesel FL; Zechmann C; Kreisel S; Vollmar F; Alonso A; Back W; Meairs S; Hennerici MG Neurosci Lett; 2008 Oct; 443(3):174-8. PubMed ID: 18691631 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of mesenchymal stem cells derived from human embryonic stem cells in transient focal cerebral ischemia in rats. Liu YP; Seçkin H; Izci Y; Du ZW; Yan YP; Başkaya MK J Cereb Blood Flow Metab; 2009 Apr; 29(4):780-91. PubMed ID: 19209181 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910 [TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. van Velthoven CT; Kavelaars A; van Bel F; Heijnen CJ Brain Behav Immun; 2010 Mar; 24(3):387-93. PubMed ID: 19883750 [TBL] [Abstract][Full Text] [Related]
8. Survival, neuron-like differentiation and functionality of mesenchymal stem cells in neurotoxic environment: the critical role of erythropoietin. Danielyan L; Schäfer R; Schulz A; Ladewig T; Lourhmati A; Buadze M; Schmitt AL; Verleysdonk S; Kabisch D; Koeppen K; Siegel G; Proksch B; Kluba T; Eckert A; Köhle C; Schöneberg T; Northoff H; Schwab M; Gleiter CH Cell Death Differ; 2009 Dec; 16(12):1599-614. PubMed ID: 19609278 [TBL] [Abstract][Full Text] [Related]
9. [Erythropoietin enhances the therapy potency of autologous bone marrow stromal cells in a rat heart infarction model via phosphatidylinositol-3-kinase/Akt pathway]. Zhang DG; Zhang FM; Zhang YQ; Zhou F; Gao X; Li CF; Cao KJ Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):912-6. PubMed ID: 17217721 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats. Pavlichenko N; Sokolova I; Vijde S; Shvedova E; Alexandrov G; Krouglyakov P; Fedotova O; Gilerovich EG; Polyntsev DG; Otellin VA Brain Res; 2008 Oct; 1233():203-13. PubMed ID: 18675258 [TBL] [Abstract][Full Text] [Related]
11. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Koh SH; Kim KS; Choi MR; Jung KH; Park KS; Chai YG; Roh W; Hwang SJ; Ko HJ; Huh YM; Kim HT; Kim SH Brain Res; 2008 Sep; 1229():233-48. PubMed ID: 18634757 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic benefit of intravenous transplantation of mesenchymal stem cells after experimental subarachnoid hemorrhage in rats. Khalili MA; Anvari M; Hekmati-Moghadam SH; Sadeghian-Nodoushan F; Fesahat F; Miresmaeili SM J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):445-51. PubMed ID: 21282068 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia. Komatsu K; Honmou O; Suzuki J; Houkin K; Hamada H; Kocsis JD Brain Res; 2010 Jun; 1334():84-92. PubMed ID: 20382136 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Liao W; Xie J; Zhong J; Liu Y; Du L; Zhou B; Xu J; Liu P; Yang S; Wang J; Han Z; Han ZC Transplantation; 2009 Feb; 87(3):350-9. PubMed ID: 19202439 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of erythropoietin effects on cerebral ischemia in rats. Aluclu MU; Acar A; Guzel A; Bahceci S; Yaldiz M Neuro Endocrinol Lett; 2007 Apr; 28(2):170-4. PubMed ID: 17435667 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Cavaglieri RC; Martini D; Sogayar MC; Noronha IL Transplant Proc; 2009 Apr; 41(3):947-51. PubMed ID: 19376395 [TBL] [Abstract][Full Text] [Related]